Three days of clinical exchange and innovation in Prague

The 2026 edition of ESSKA Congress in Prague was an exciting experience for the Movmedix team. Over three days, we had the opportunity to meet surgeons, partners and healthcare professionals from around the world, all driven by the same objective: advancing orthopedic surgery and sports medicine through innovation and clinical collaboration.

Our participation began on a particularly meaningful note, as the opening day of ESSKA aligned with International Clinical Trials Day, a strong reminder of the importance of research and evidence-based innovation in our field. We were also proud to see two scientific posters featuring LARS® ligaments presented during the congress. These clinical studies from Italy and Greece highlighted the use of LARS® in ACL reconstruction and autograft reinforcement using different surgical techniques. 

Beyond the congress itself, one of the highlights of the week was our scientific cocktail hosted in the heart of Prague. The evening brought together surgeons and partners for insightful discussions around intra- and extra-articular applications of LARS® ligaments, reconstruction and reinforcement strategies to optimize recovery and return to sport.

We would like to warmly thank our faculty experts, Dr. Gianluca Camillieri and Dr. David Sime, for the quality of their presentations and for sharing their valuable clinical experience with participants from all over the world.

Finally, a sincere thank you to everyone who visited us at our booth throughout the congress. The discussions, meetings and exchanges we shared during ESSKA 2026 continue to strengthen our commitment to innovation, clinical collaboration and the development of solutions designed to support surgeons and patients every day.